Livestreaming Platform Supported by:

custom image custom image custom image

32nd Annual North American Cystic Fibrosis Conference

W03--CLIN: Gastroenterology & Hepatology

Oct 18, 2018 9:45am ‐ Oct 18, 2018 11:05am


Description

This session will highlight recent research studying assessment and treatment of the gastrointestinal and liver manifestations of cystic fibrosis. The session will focus on: 1) assessment of common CF gastrointestinal problems, including development of innovative therapies; and 2) clinical research to better understand manifestations of and outcomes for CF-related liver disease.

Learning Objectives:

  • Recall the definition of CF-related liver disease and appraise the associations of CF-related liver disease with insulin resistance and mortality.
  • Examine methods for novel drug development and application in constipation in CF.
  • Assess esophageal impedance and gut microbiota dysbiosis in pediatric patients with CF.

Workshop Chair(s):

Workshop Speaker(s):

You must be logged in and own this session in order to post comments.